REGISTERED NUMBER: 10051045 (England and Wales)

Professor Persad Medical Consulting

Limited

Unaudited Financial Statements for the Year Ended 31 March 2025

Page

Company Information

1

Balance Sheet

2

DIRECTOR:

R A Persad

REGISTERED OFFICE:

One New Street

Wells

Somerset

BA5 2LA

REGISTERED NUMBER:

10051045 (England and Wales)

ACCOUNTANTS:

Webb & Co Ltd

Accountants and Business Advisers

One New Street

Wells

Somerset

BA5 2LA

FIXED ASSETS

3,991

7,761

CURRENT ASSETS

310,115

190,785

PREPAYMENTS AND ACCRUED INCOME

317

660

CREDITORS

Amounts falling due within one year

(27,746

)

(726

)

NET CURRENT ASSETS

282,686

190,719

TOTAL ASSETS LESS CURRENT LIABILITIES

286,677

198,480

ACCRUALS AND DEFERRED INCOME

(3,060

)

(2,433

)

NET ASSETS

283,617

196,047

CAPITAL AND RESERVES

283,617

196,047

NOTES TO THE FINANCIAL STATEMENTS

1.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 3 (2024 - 4 ) .

2.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

2025

2024

£

£

R A Persad

Balance outstanding at start of year

29,864

1,294

Amounts advanced

-

29,864

Amounts repaid

(29,864

)

(1,294

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

-

29,864

Interest has been charged at HMRC rates.

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 23 December 2025 and were signed by:

R A Persad - Director